Insight

Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery

Photo taken from Anne Knisely/LinkedIn

Aug 27, 2024, 02:59

Anne Knisely: Metronidazole and Cefazolin for SSI prophylaxis in gynaecological surgery

Anne Knisely, Gynaecology and Oncology fellow at MD Anderson Cancer Center, shared a post by AJOG on X, adding:

“Excited to share our QI paper published in AJOG. If you’re not already adding metronidazole to cefazolin for SSI prophylaxis in gynaecological surgery, you should start!

Adjusted OR for SSI 0.49 decrease with addition of metronidazole.”

Quoting AJOG’s post:

“Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center.”

Source: Anne Knisely/X and AJOG/X

Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center.

Authors: Anne Knisely, Maria D. Iniesta, Claire A. Marten, Gary Chisholm, Kathleen M. Schmeler, and Jolyn S. Taylor.

Anne Knisely

AJOG Anne Knisely cancer cefazolin Claire A. Marten Gary Chisholm gynecologic surgery Jolyn S. Taylor Kathleen M. Schmeler Maria D. Iniesta Metronidazole OncoDaily Oncology SSI prophylaxis

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity